在2型糖尿病患者中使用ORPHÉ ANALYTICS进行步态分析的可靠性:单中心观察性研究
Takaaki Matsuda1,2, Yoshinori Osaki3, Hirofumi Takahashi4
1Department of Endocrinology and Metabolism, University of Tsukuba Hospital, Tsukuba, Japan.
JMA journal
|August 11, 2025
概括
这项研究发现,ORPHÉ ANALYTICS系统在2型糖尿病 (T2D) 患者的步态分析中显示出良好的可靠性,特别是在评估者内部的评估中. 然而,评审者之间的可靠性有所不同,这表明使用单个检查员来获得一致的结果.
科学领域:
- 生物医学工程 生物医学工程
- 临床生物力学 临床生物力学
- 糖尿病研究 糖尿病研究
背景情况:
- 在糖尿病患者中,行走异常很常见.
- 惯性测量单元 (IMU) 提供便携式步态分析替代方案.
- 在不同条件下的2型糖尿病 (T2D) 中,基于IMU的步态分析的可靠性尚未得到充分证实.
研究的目的:
- 评估ORPHÉ ANALYTICS基于IMU的步态分析系统的可靠性.
- 在T2D患者的不同测量条件下 (距离,时间,检查人员) 评估可靠性.
主要方法:
- 一个单一中心的观察性研究,包括9名T2D患者.
- 评估了ORPHÉ ANALYTICS系统在评价者内部和评价者内部的可靠性.
- 在不同的距离 (10m vs. 30m),检查员和时间 (早上 vs. 下午) 中使用了类内相关系数 (ICC).
主要成果:
- 对于大多数步态参数,具有优异的级别内可靠性 (ICC ≥0.9).
- 在距离和时间变化方面具有良好的评分间可靠性 (ICC ≥0.75).
- 在不同检查者之间,中等到良好的评分器间可靠性 (ICC ≥0.50),在摇摆和脚角度上有显著的新奇差异,并且>40%的随机错误.
结论:
- ORPHE ANALYTICS在关于距离和时间的内部和内部评估方面表现出良好的可靠性.
- 在T2D患者中,评估者之间的可靠性挑战仍然存在,这表明需要单个检查员分析.
- 该系统显示了T2D中步态分析的潜力,但检查员的一致性至关重要.
相关概念视频
01:22Diabetes Mellitus: Type 2 and Gestational
4.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
342
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
342
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
993
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
993
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
17
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17